This podcast is part of the Life Sciences 2030 initiative that explores ethics of artificial intelligence (AI) in the life sciences industry. Moderated by Kristen Backor with panelists Michelle Guo, Travis Ruch, and Artes Haderi, the discussion highlights AI’s potential to revolutionize drug development, patient care, and healthcare efficiency while emphasizing the ethical challenges such as biases in AI models, regulatory considerations, and the impact on health disparities. The conversation also addresses the role of policymakers in ensuring ethical AI implementation in healthcare and discusses real-world examples, potential future applications, and the importance of using real-world evidence to improve clinical trials and patient outcomes.
Listen and follow CRA on Spotify.
